June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Detecting glaucoma progression using optic nerve volume scans with three-dimensional spectral-domain optical coherence tomography
Author Affiliations & Notes
  • Kitiya Ratanawongphaibul
    Ophthalmology, Chulalongkorn University, Bangkok, Bangkok, Thailand
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
  • Teresa C Chen
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Medical School, Boston, Massachusetts, United States
  • Edem Tsikata
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Medical School, Boston, Massachusetts, United States
  • Michele Zemplenyi
    Biostatistics, Harvard University T H Chan School of Public Health, Boston, Massachusetts, United States
  • Hang Lee
    Harvard Medical School, Boston, Massachusetts, United States
    Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States
  • Milica Margeta
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Medical School, Boston, Massachusetts, United States
  • Courtney Ondeck
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Medical School, Boston, Massachusetts, United States
  • Janice Kim
    Harvard Medical School, Boston, Massachusetts, United States
  • Billy Pan
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Medical School, Boston, Massachusetts, United States
  • Paul Petrakos
    Ophthalmology, Massachusetts Eye and Ear Infirmary Department of Ophthalmology, Boston, Massachusetts, United States
    Harvard Medical School, Boston, Massachusetts, United States
  • Anne L Coleman
    Jules Stein Eye Institute, Los Angeles, California, United States
  • Fei Yu
    Jules Stein Eye Institute, Los Angeles, California, United States
  • Johannes de Boer
    Ophthalmology, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands
  • Footnotes
    Commercial Relationships   Kitiya Ratanawongphaibul, None; Teresa Chen, None; Edem Tsikata, None; Michele Zemplenyi, None; Hang Lee, None; Milica Margeta, None; Courtney Ondeck, None; Janice Kim, None; Billy Pan, None; Paul Petrakos, None; Anne Coleman, None; Fei Yu, None; Johannes de Boer, Heidelberg Engineering (F), NIDEK Inc. (F), Ninepoint Medical (F), Terumo Corporation (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1857. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kitiya Ratanawongphaibul, Teresa C Chen, Edem Tsikata, Michele Zemplenyi, Hang Lee, Milica Margeta, Courtney Ondeck, Janice Kim, Billy Pan, Paul Petrakos, Anne L Coleman, Fei Yu, Johannes de Boer; Detecting glaucoma progression using optic nerve volume scans with three-dimensional spectral-domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1857.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine whether three-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) neuroretinal rim measurements detect glaucoma progression earlier than current standard of care clinical testing i.e., disc photography (DP), visual field (VF) testing, and two-dimensional (2D) retinal nerve fiber layer (RNFL) thickness measurements.

Methods : In this 5-year prospective longitudinal cohort study, 124 eyes of 124 open angle glaucoma patients had yearly DP, VFs, SD-OCT RNFL thickness scans, and optic nerve volume scans (Spectralis, Heidelberg Engineering, Heidelberg, Germany) which were performed on the same day. From high-density optic nerve volume scans, custom-built software calculated the minimum distance band (MDB) thickness, a 3D neuroretinal rim parameter, which quantifies the amount of tissue in the neuroretinal rim. Patients were classified as glaucoma progressors or non-glaucoma progressors using event-based analysis. Progression by DP and VF were determined when 3 masked glaucoma specialists unanimously concurred. Progression by RNFL and MDB thickness were determined if there was change greater than test-retest variability. Kaplan-Meier curves were constructed to analyze time-to-progression data.

Results : Global MDB neuroretinal rim thickness detected glaucoma progression earlier either DP (23 versus 44 months; P<0.001) or global RNFL thickness (23 versus 33 months; P<0.001). Global MDB thickness also detected progression slightly earlier than visual fields (23 versus 32 months), but the difference was not statistically significant (P=0.15).

Conclusions : High-density 3D SD-OCT neuroretinal rim measurements detected glaucoma progression approximately 1-2 years earlier compared to current clinically available structural tests (i.e., DP and 2D RNFL thickness measurements).

This is a 2021 ARVO Annual Meeting abstract.

 

Comparison of event-based progression analysis using Kaplan-Meier curves for visual field (VF) testing, global two-dimensional (2D) retinal nerve fiber layer (RNFL) thickness, global three-dimensional (3D) neuroretinal rim thickness, and disc photography (DP). The global 3D neuroretinal rim thickness detected glaucoma progression significantly earlier than current clinically available structural tests [i.e. global RNFL thickness and DP (P<0.001)].

Comparison of event-based progression analysis using Kaplan-Meier curves for visual field (VF) testing, global two-dimensional (2D) retinal nerve fiber layer (RNFL) thickness, global three-dimensional (3D) neuroretinal rim thickness, and disc photography (DP). The global 3D neuroretinal rim thickness detected glaucoma progression significantly earlier than current clinically available structural tests [i.e. global RNFL thickness and DP (P<0.001)].

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×